Digital therapeutics - The regulatory support has facilitated the establishment of a standard developmental pathway Digital therapeutics are clinically validated applications / software / online programs that have demonstrated the capability to facilitate positive outcomes when used in the prevention / treatment / management of diseases / clinical conditions. Digital Therapeutics, popularly known as DTx, represent a digital health solution which delivers medical interventions directly to the patients in order to treat, manage and prevent a disease. These therapeutics are designed to engage patients in personalized treatment or disease prevention programs, through mediating behavioral or psychological modifications, providing motivational support and inculcating healthy lifestyle changes. Several organizations have undertaken diverse initiatives in the field of digital therapeutics to support its growth as a new frontier in the healthcare sector. A number of organizations focused on effectively monitoring and promoting the potential of digital therapeutics to be used as a part of strategies to improve the population health have also been established. These organizations include:  Digital Therapeutics Alliance (DTA)  Personal Connected Health (PCH) Alliance  Centers for Disease Control and Prevention (CDC)  Health Insurance Portability and Accountability Act (HIPAA)  National Health Service (NHS)  United States Food and Drug Administration (USFDA) For additional details, please visit https://www.rootsanalysis.com/reports/view_document/digital-health-market/208.html or email sales@rootsanalysis.com